Interleukin-4/13 Trap

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-4/13 Trap

Drug Alias NameInterleukin-4/13 antagonist - RegeneronIL-4/13 antagonist - RegeneronIL-4/13 Trap - RegeneronInterleukin-4/13 Trap - RegeneronIL-4/IL-13 trap

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin-13 inhibitorsInterleukin-4 inhibitors

TargetsInterleukin-4Interleukin-13

Therapy Area/IndicationsHypersensitivityAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRegeneron Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRegeneron Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A